Department of Pediatrics, Nepalgunj Medical College, Nepalgunj, Banke.
Chief consultant physician and head of department of Medicine, Bheri hospital, Nepalgunj, Banke.
J Nepal Health Res Counc. 2023 Jul 20;20(4):834-837. doi: 10.33314/jnhrc.v20i4.3719.
Beta thalassemias are extremely heterogenous hereditary monogenic blood disorders and preventable genetic hemolytic anemia caused by >200 mutations in HBB gene. In Nepal, it is more prevalent in Tharu tribe but it seen in other communities as well. Out of more than 200 mutations of beta globin gene, approximate 20 different alleles are responsible for >80% of the mutations. Mutations vary in different geographic population and are responsible for manifestation of different phenotypes. This study was done to find common mutations of HBB gene in Nepal which were responsible for different phenotypic manifestations and to know clinical severity according to the mutations.
This was a descriptive, cross sectional study conducted in the pediatric and medicine department of Nepalgunj Medical College and Bheri Zonal Hospital, Nepalgunj from January 2020 to December 2020. The genotype and phenotype profiles of thalassemia cases were reported. The data was analyzed by SPSS 20.
The results obtained showed that clinical presentation differed with different β-globin gene mutations present. Individuals with HBB:c.47G>A and HBB:c.20A>T/ c.79G>A mutations showed milder presentation than those with HBB:c.47G>A/-619del and HBB:c.20A>T/c.47G>A.
Therefore, these findings can be used to predict clinical severity so that we can take appropriate measures by early genotype identification for prenatal diagnosis of beta thalassemia.
β地中海贫血症是一种极其多样的遗传性单基因血液疾病,由 HBB 基因中的 >200 种突变引起可预防的遗传性溶血性贫血。在尼泊尔,它在 Tharu 部落更为普遍,但在其他社区也有发现。在超过 200 种β球蛋白基因突变中,大约有 20 种不同的等位基因负责 >80%的突变。突变在不同的地理人群中有所不同,导致不同表型的表现。本研究旨在发现尼泊尔 HBB 基因的常见突变,这些突变导致不同的表型表现,并根据突变了解临床严重程度。
这是一项在尼泊尔甘吉医学院和尼泊尔甘吉 Bheri 地区医院儿科和医学系进行的描述性、横断面研究。报告了地中海贫血病例的基因型和表型谱。数据使用 SPSS 20 进行分析。
研究结果表明,不同的β-球蛋白基因突变导致不同的临床表现。与 HBB:c.47G>A 和 HBB:c.20A>T/c.79G>A 突变的个体相比,具有 HBB:c.47G>A/-619del 和 HBB:c.20A>T/c.47G>A 突变的个体表现更为轻微。
因此,这些发现可用于预测临床严重程度,以便我们可以通过早期基因型识别,为β地中海贫血症的产前诊断采取适当措施。